1
. Whereas plain radiographs demonstrate established bony damage, ultrasound can highlight ongoing synovial inflammation, nonradiographic bony erosion and soft tissue pathology. This has augmented the assessment of inflammatory polyarthropathies and aided in clinical decision-making.
Whilst limitations in intra-operator variability and reproducibility have been cited, education through both practical and on-line musculoskeletal ultrasound courses is helping to address these caveats 2 . With tailored standardised training, incorporated into the rheumatology curriculum, confidence in point of care scanning will increase.
What does this mean for the future? Working groups such as the OMERACT ultrasound group are evaluating its role as an outcome measure 3 . Issues remain in cases where there is clinical disease remission but ongoing ultrasonographic evidence of active synovitis. Ultrasound based synovitis has been suggested to predict radiographic damage. Will this mean the need to escalate treatment in a case of clinical remission? Furthermore, will outcome measures such as the DAS28 joint score require enhancement or even replacement with ultrasound based scores? Some clinical trial data to date has shown no significant difference at primary outcome points but this is in need of further evaluation 4 . We guess time will tell. Acute upper gastrointestinal bleeding (UGIB) is a common presentation to emergency departments and is associated with significant morbidity and mortality (5-10%). While blood transfusion may be part of the management, the most effective red cell transfusion strategy is debatable.
A 6-year European prospective randomised trial of 889 patients presenting with upper GI bleeding showed a restrictive transfusion strategy was associated with significantly better outcomes when compared to liberal transfusion. Outcomes, including rebleeding (10% v 16%) and adverse events (40% v 48%), were significantly better with a transfusion haemoglobin (Hb) threshold of 7g/dL when compared to 9g/dL. Survival was also improved in peptic ulcer and cirrhotic Child-Pugh A & B patients. 1 In addition to UGIB, a meta-analysis has shown in patients with a critical illness and a GI bleed, that cardiac events, infections and overall mortality are reduced when a restrictive blood transfusion approach is implemented.
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A restrictive transfusion strategy should be considered in the management of patients with acute UGIB. We suggest transfusing only when Hb is less than 7 g/dL, and aiming for a target of 7 -9 g/dl. The exception when Hb threshold for transfusion may be higher may be the haemodynamically unstable patient and those with recent symptomatic cardiovascular disease. The ongoing TRIGGER trial will assess the feasibility of implementing a restrictive vs liberal red blood cell transfusion policy for adult patients with UGIB in the UK. 
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